http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106868191-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2017-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106868191-B |
| titleOfInvention | Application of the eukaryotic translation elongation factors in detection breast cancer reagent |
| abstract | The invention discloses application of the eukaryotic translation elongation factors in detection breast cancer reagent, and the eukaryotic translation elongation factors include eukaryotic translation extension factor 1 δ and eukaryotic translation elongation factor 2.The present invention further discloses the reagent of the detection susceptible SNP site genotype of eukaryotic translation elongation factors and its kits of preparation.The development and application that the present invention passes through the SNP biomarker and diagnostic kit of eukaryotic translation elongation factors, it may make the diagnosis of breast cancer more convenient and easy, conditions of patients is quick and precisely grasped for clinician, it lays the foundation for clinical therapeutic efficacy evaluation, and provide help to be found to have the new small molecule drug targets of potential treatment value. |
| priorityDate | 2017-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.